{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:54:41Z","timestamp":1791860081869,"version":"4.3.4"},"reference-count":163,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Delivery"],"published-print":{"date-parts":[[2024,6,2]]},"DOI":"10.1080\/20415990.2024.2346047","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T08:28:26Z","timestamp":1718094506000},"page":"463-480","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Recent updates on ocular disease management with ophthalmic ointments"],"prefix":"10.1080","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4841-0140","authenticated-orcid":false,"given":"Amol Chhatrapati","family":"Bisen","sequence":"first","affiliation":[{"name":"Pharmaceutics &amp; Pharmacokinetics Division, CSIR-Central Drug Research Institute, Lucknow, 226031, Uttar Pradesh, India"},{"name":"Academy of Scientific &amp; Innovative Research (AcSIR), Ghaziabad, 201002, Uttar Pradesh, India"},{"name":"Sophisticated Analytical Instrument Facility and Research,\u00a0CSIR-Central Drug Research Institute,\u00a0Lucknow, 226031,\u00a0Uttar Pradesh,\u00a0India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5477-4300","authenticated-orcid":false,"given":"Ayush","family":"Dubey","sequence":"additional","affiliation":[{"name":"Pharmaceutics &amp; Pharmacokinetics Division, CSIR-Central Drug Research Institute, Lucknow, 226031, Uttar Pradesh, India"},{"name":"School of Pharmaceutical Sciences, CSJM University, Kanpur, 208024, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4656-131X","authenticated-orcid":false,"given":"Sristi","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Pharmaceutics &amp; Pharmacokinetics Division, CSIR-Central Drug Research Institute, Lucknow, 226031, Uttar Pradesh, India"},{"name":"Academy of Scientific &amp; Innovative Research (AcSIR), Ghaziabad, 201002, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3755-407X","authenticated-orcid":false,"given":"Arpon","family":"Biswas","sequence":"additional","affiliation":[{"name":"Pharmaceutics &amp; Pharmacokinetics Division, CSIR-Central Drug Research Institute, Lucknow, 226031, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8436-7122","authenticated-orcid":false,"given":"Kundan Singh","family":"Rawat","sequence":"additional","affiliation":[{"name":"Prof. Rajendra Singh Nanoscience &amp; Chemistry D.S.B. Campus, Kumaun University, Nainital, 263001, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Pharmaceutics &amp; Pharmacokinetics Division, CSIR-Central Drug Research Institute, Lucknow, 226031, Uttar Pradesh, India"},{"name":"School of Pharmaceutical Sciences, CSJM University, Kanpur, 208024, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4844-2388","authenticated-orcid":false,"given":"Rabi Sankar","family":"Bhatta","sequence":"additional","affiliation":[{"name":"Pharmaceutics &amp; Pharmacokinetics Division, CSIR-Central Drug Research Institute, Lucknow, 226031, Uttar Pradesh, India"},{"name":"Academy of Scientific &amp; Innovative Research (AcSIR), Ghaziabad, 201002, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2018.01.120"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108230"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2022.101157"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i1.92"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/jof8101078"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31550-2"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2023.0068"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.21"},{"key":"e_1_3_6_11_1","first-page":"1","article-title":"Cataract","volume":"1","author":"Lam D","year":"2015","unstructured":"Lam D, Rao SK, Ratra V, et al. Cataract. Nat Rev Dis Prim. 2015;1:1\u201315.","journal-title":"Nat Rev Dis Prim."},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000000447"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2016.1196713"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/9781555819040.ch4"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/09286580701501931"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161209788923886"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02516-9"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10010010"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2012.10.005"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.4155\/tde.14.75"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121105"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2022.2103600"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02516-9"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2023.0166"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.10.058"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(97)00002-5"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.03.039"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1081\/DDC-120003445"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2009.02.003"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-010-9183-3"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.4155\/tde.10.40"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2023.0089"},{"key":"e_1_3_6_33_1","first-page":"961","article-title":"Drug delivery for posterior segment eye disease","volume":"41","author":"Geroski D","year":"2000","unstructured":"Geroski D, Edelhauser H. Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci. 2000;41:961\u2013964.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.12276"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2007.11.002"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.56770\/jcp201702"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-219907"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(78)90178-9"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v16.i1.20"},{"key":"e_1_3_6_40_1","first-page":"149","article-title":"New ophthalmic drug delivery systems","volume":"44","author":"Castro-Balado A","year":"2020","unstructured":"Castro-Balado A, Mondelo-Garc\u00eda C, Zarra-Ferro I, et al. New ophthalmic drug delivery systems. Farm Hosp. 2020;44:149\u2013157.","journal-title":"Farm Hosp."},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.25004\/IJPSDR.2009.010101"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.08.096"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(75)90883-1"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2018.016"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202301389"},{"key":"e_1_3_6_46_1","first-page":"323","article-title":"Employment opportunities in solar energy sector","volume":"6","author":"Bokil P","year":"2022","unstructured":"Bokil P, Sanap G, Shubhangi Manikpuriya SMM. Employment opportunities in solar energy sector. Int J Adv Res Sci Commun Technol. 2022;6:323\u2013335.","journal-title":"Int J Adv Res Sci Commun Technol."},{"key":"e_1_3_6_47_1","first-page":"99","volume-title":"Shaw CBT-EC for F of S and LD.","author":"Shaw C","year":"2016","unstructured":"Shaw C. Chapter 7 \u2013 Preparation and Stability Testing. In: Kulkarni VS, editor. Shaw CBT-EC for F of S and LD. Boston: Academic Press; 2016. p. 99\u2013135."},{"key":"e_1_3_6_48_1","first-page":"188","article-title":"Assessment of the precorneal residence of an ophthalmic ointment in healthy subjects","volume":"35","author":"Greaves JL","year":"1993","unstructured":"Greaves JL, Wilson CG, Birmingham AT. Assessment of the precorneal residence of an ophthalmic ointment in healthy subjects. Br J Clin Pharmacol. 1993;35:188.","journal-title":"Br J Clin Pharmacol."},{"key":"e_1_3_6_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/7653_2013_9"},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2023.102064"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-023-05977-7"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.5603\/OJ.2021.0009"},{"key":"e_1_3_6_53_1","first-page":"2","article-title":"Preservatives from the eye drops and the ocular surface","volume":"59","author":"Coroi MC","year":"2015","unstructured":"Coroi MC, Bungau S, Tit M. Preservatives from the eye drops and the ocular surface. Rom J Ophthalmol. 2015;59:2.","journal-title":"Rom J Ophthalmol."},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1586\/17469899.4.1.59"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.2c00673"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2023.113316"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.3c00795"},{"key":"e_1_3_6_58_1","volume-title":"A Pract Guid to Contemp Pharm Pract.","author":"De Villiers MM","year":"2009","unstructured":"De Villiers MM, Marques M, Mille Y, et al. Ointment Bases. In: Thompson JE, editor. A Pract Guid to Contemp Pharm Pract. 3rd ed. Judith E Thompson; 2009.","edition":"3"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.04.075"},{"key":"e_1_3_6_60_1","first-page":"335","article-title":"A review on: ointment and ointment bases","volume":"5","author":"Bhaskar R","year":"2016","unstructured":"Bhaskar R, Ola M, Patil PH, et al. A review on: ointment and ointment bases. World J Pharm Res. 2016;5:335\u2013345.","journal-title":"World J Pharm Res."},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004397-198002030-00009"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-008-9024-9"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713688709020096"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.5497\/wjp.v2.i2.47"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.11.005"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.09.016"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2024.108702"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1039\/D0BM01033B"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2019.05.035"},{"key":"e_1_3_6_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.08.138"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2017.1272569"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02673-x"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.4155\/tde-2023-0031"},{"key":"e_1_3_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2013.10.008"},{"key":"e_1_3_6_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2015.05.002"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-0731"},{"key":"e_1_3_6_77_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006512"},{"key":"e_1_3_6_78_1","doi-asserted-by":"publisher","DOI":"10.1021\/js9802594"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2010.12.037"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11070321"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-016-0339-2"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.3906\/elk-1905-42"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103517"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2023-0233"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1039\/D3AY00317E"},{"key":"e_1_3_6_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5681"},{"key":"e_1_3_6_87_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5600"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037660"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103721"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033775"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/jms.5031"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101944"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612829666230707121415"},{"key":"e_1_3_6_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-009-0708-6"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.15218\/zjms.2009.023"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-002-0219-1"},{"key":"e_1_3_6_97_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001206"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1993.01090090062020"},{"key":"e_1_3_6_99_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018980"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcgg.2010.10.006"},{"key":"e_1_3_6_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1988.61"},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12060570"},{"key":"e_1_3_6_103_1","doi-asserted-by":"publisher","DOI":"10.3109\/13816810.2015.1016241"},{"key":"e_1_3_6_104_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099036"},{"key":"e_1_3_6_105_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15080985"},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2004.12.007"},{"key":"e_1_3_6_107_1","doi-asserted-by":"publisher","DOI":"10.1177\/25158414231173532"},{"key":"e_1_3_6_108_1","doi-asserted-by":"publisher","DOI":"10.1080\/01496395.2022.2160349"},{"key":"e_1_3_6_109_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181d83875"},{"key":"e_1_3_6_110_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-019-04287-1"},{"key":"e_1_3_6_111_1","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2012.26.4.241"},{"key":"e_1_3_6_112_1","doi-asserted-by":"publisher","DOI":"10.1208\/pt070496"},{"key":"e_1_3_6_113_1","first-page":"CD014617","article-title":"Antibiotic prophylaxis for corneal abrasion","volume":"5","author":"Algarni AM","year":"2022","unstructured":"Algarni AM, Guyatt GH, Turner A, et al. Antibiotic prophylaxis for corneal abrasion. Cochrane Database Syst Rev. 2022;5:CD014617.","journal-title":"Cochrane Database Syst Rev."},{"key":"e_1_3_6_114_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.081224"},{"key":"e_1_3_6_115_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-199405030-00002"},{"key":"e_1_3_6_116_1","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2017.1339805"},{"key":"e_1_3_6_117_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-0275"},{"key":"e_1_3_6_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2019.09.001"},{"key":"e_1_3_6_119_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31820ce56c"},{"key":"e_1_3_6_120_1","volume-title":"StatPearls.","author":"Duplechain A","year":"2023","unstructured":"Duplechain A, Conrady CD, Patel BC, et al. Uveitis. StatPearls. Treasure Island (FL); 2023."},{"key":"e_1_3_6_121_1","doi-asserted-by":"publisher","DOI":"10.1002\/hcs2.57"},{"key":"e_1_3_6_122_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000579"},{"key":"e_1_3_6_123_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081227"},{"key":"e_1_3_6_124_1","doi-asserted-by":"publisher","DOI":"10.1002\/bip.23578"},{"key":"e_1_3_6_125_1","doi-asserted-by":"publisher","DOI":"10.1002\/mba2.77"},{"key":"e_1_3_6_126_1","doi-asserted-by":"publisher","DOI":"10.1088\/0957-4484\/25\/12\/125101"},{"key":"e_1_3_6_127_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.83.7.767"},{"key":"e_1_3_6_128_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713688509003350"},{"key":"e_1_3_6_129_1","volume-title":"Ectropion.","author":"Ozgur O","year":"2023","unstructured":"Ozgur O, Kaufman EJ. Ectropion. Treasure Island (FL); 2023."},{"key":"e_1_3_6_130_1","doi-asserted-by":"publisher","DOI":"10.4103\/jwas.jwas_67_22"},{"key":"e_1_3_6_131_1","unstructured":"Kato M Kido K Oda T. Ursodeoxycholic acid-containing agent for treating or preventing presbyopia. Japan: United States Patent; 2019."},{"key":"e_1_3_6_132_1","first-page":"1","volume-title":"Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockage.","author":"Kido K","year":"2018","unstructured":"Kido K, Nagano T. Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockage. Japan; 2018. p. 1\u20136."},{"key":"e_1_3_6_133_1","first-page":"1","volume-title":"Ocular Formulations of Norketotifen.","author":"Aberg AKG","year":"2015","unstructured":"Aberg AKG, Johnson K. Ocular Formulations of Norketotifen. United States: United States Patent; 2015. p. 1\u201315."},{"key":"e_1_3_6_134_1","first-page":"1","volume-title":"Use of complement inhibitors to treat ocular diseases.","author":"Fung SC","year":"2014","unstructured":"Fung SC, Yao Z. Use of complement inhibitors to treat ocular diseases. United States: United States Patent; 2014. p. 1\u20135."},{"key":"e_1_3_6_135_1","first-page":"1","volume-title":"Folic acid \u2013 Ramipril combination: cellprotective, neuroprotective and retinoprotective ophtalmologic compositions.","author":"Rekik R","year":"2012","unstructured":"Rekik R. Folic acid \u2013 Ramipril combination: cellprotective, neuroprotective and retinoprotective ophtalmologic compositions. Australia: Australian Patent Office; 2012. p. 1\u201334."},{"key":"e_1_3_6_136_1","first-page":"1","volume-title":"Therapeutic Compositions for the Treatment of Dry Eye Disease.","author":"Dana R","year":"2011","unstructured":"Dana R, Chauhan S. Therapeutic Compositions for the Treatment of Dry Eye Disease. United States: United States Patent; 2011. p. 1\u201310."},{"key":"e_1_3_6_137_1","first-page":"1","volume-title":"Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing\/dispersing agent.","author":"Aukunuru J","year":"2006","unstructured":"Aukunuru J, Saunier MB, Bizec J, et al. Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing\/dispersing agent. United States Patent; 2006. p. 1\u201310."},{"key":"e_1_3_6_138_1","volume-title":"Ophthalmic ointments for treating infective eye disease.","author":"Kasama T","year":"2005","unstructured":"Kasama T, Noto M, Oguro T, et al. Ophthalmic ointments for treating infective eye disease. Japan: United States Patent; 2005."},{"key":"e_1_3_6_139_1","first-page":"1","volume-title":"Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye.","author":"Chen J","year":"2003","unstructured":"Chen J, Liu Y. Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye. United States: United States; 2003. p. 1\u20138."},{"key":"e_1_3_6_140_1","first-page":"1","volume-title":"Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor.","author":"Thomas PG","year":"1998","unstructured":"Thomas PG. Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor. United States: United States Patent; 1998. p. 1\u20139."},{"key":"e_1_3_6_141_1","volume-title":"Ophthalmic ointments for the treatment of glaucoma, comprising ergot alkaloids.","author":"Djordjevic ND","year":"1989","unstructured":"Djordjevic ND, Kofler B, Kramaric A, et al. Ophthalmic ointments for the treatment of glaucoma, comprising ergot alkaloids. Slovenia: European Patent Office; 1989."},{"key":"e_1_3_6_142_1","volume-title":"Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis.","author":"Hospital NTU","year":"2018","unstructured":"Hospital NTU. Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis. Taiwan; 2018."},{"key":"e_1_3_6_143_1","volume-title":"Efficacy of Loteprednol Ointment Following Eyelid Surgery.","author":"Bobby Korn","year":"2019","unstructured":"Bobby Korn. Efficacy of Loteprednol Ointment Following Eyelid Surgery. San Diego; 2019."},{"key":"e_1_3_6_144_1","volume-title":"A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED).","author":"Azura Ophthalmics","year":"2022","unstructured":"Azura Ophthalmics. A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED). New South Wales, Australia; 2022."},{"key":"e_1_3_6_145_1","volume-title":"Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction.","author":"Qi H","year":"2022","unstructured":"Qi H. Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction. Beijing, China; 2022."},{"key":"e_1_3_6_146_1","volume-title":"Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC).","author":"Siriraj Hospital","year":"2005","unstructured":"Siriraj Hospital. Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC). Bangkok, Thailand; 2005."},{"key":"e_1_3_6_147_1","volume-title":"Village Integrated Eye Workers Trial (VIEW).","author":"University of California","year":"2023","unstructured":"University of California. Village Integrated Eye Workers Trial (VIEW). Bharatpur, Nepal; 2023."},{"key":"e_1_3_6_148_1","unstructured":"Bausch & Lomb Incorporated. Atropine sulfate ointment [Internet]. 1990. Available from: https:\/\/www.webmd.com\/drugs\/2\/drug-8614-5099\/atropine-ophthalmic-eye\/atropine-sulfate-ointment-ophthalmic\/details"},{"key":"e_1_3_6_149_1","unstructured":"FDC Ltd. Zoxan eye ointment [Internet]. Available from: https:\/\/www.1mg.com\/drugs\/zoxan-eye-ointment-565913"},{"key":"e_1_3_6_150_1","unstructured":"Entod Pharmaceuticals Ltd. Omeflox BM eye ointment [Internet]. Available from: https:\/\/www.1mg.com\/drugs\/omeflox-bm-eye-ointment-250604"},{"key":"e_1_3_6_151_1","first-page":"86","article-title":"Recent trends in ocular drug delivery: a short review recent trends in ocular drug delivery: a short review","volume":"3","author":"Kumar A","year":"2011","unstructured":"Kumar A, Malviya R, Sharma P. Recent trends in ocular drug delivery: a short review recent trends in ocular drug delivery: a short review. Eur J Appl Sci. 2011;3:86\u201392.","journal-title":"Eur J Appl Sci."},{"key":"e_1_3_6_152_1","unstructured":"Spectra Vision Care. Remoxy eye ointment [Internet]. Available from: https:\/\/www.spectravisioncare.in\/product\/moxifloxacin-eye-ointment"},{"key":"e_1_3_6_153_1","unstructured":"Pharmaceuticals K. Newflo eye ointment [Internet]. Available from: https:\/\/kaizenpharmaceuticals.in\/product\/newflo-ointment\/"},{"key":"e_1_3_6_154_1","unstructured":"Glaxo SmithKline Pharmaceuticals Ltd. Neosporin eye ointment [Internet]. Available from: https:\/\/india-pharma.gsk.com\/media\/6392\/neosporin-ointment.pdf"},{"key":"e_1_3_6_155_1","unstructured":"RGS Pharmaceuticals Private Limited. RG TOB [Internet]. Available from: https:\/\/www.indiamart.com\/proddetail\/tobramycin-eye-ointment-25857517012.html"},{"key":"e_1_3_6_156_1","unstructured":"Biocon Biologics India Limited. TBIS 0.1% [Internet]. Available from: https:\/\/www.apollopharmacy.in\/medicine\/tbis-0-1-ointment-10gm"},{"key":"e_1_3_6_157_1","unstructured":"Medicom Healthcare Ltd. Golden Eye ointment [Internet]. Available from: https:\/\/www.goldeneyecare.co.uk\/assets\/leaflets\/Golden-Eye-Chloramphenicol-1-EO-PV5-TUB.pdf"},{"key":"e_1_3_6_158_1","unstructured":"Syntho Pharma. Cortecycline eye ointment [Internet]. Available from: https:\/\/www.1mg.com\/drugs\/cortecycline-eye-ointment-146177"},{"key":"e_1_3_6_159_1","unstructured":"Optho Pharma Pvt. Ltd. NACL 6 eye ointment [Internet]. Available from: https:\/\/www.1mg.com\/drugs\/nacl-6-eye-ointment-234949"},{"key":"e_1_3_6_160_1","unstructured":"Sensomed. Sensomed Erythromycin [Internet]. Available from: https:\/\/www.mims.com\/philippines\/drug\/info\/sensomed%20erythromycin"},{"key":"e_1_3_6_161_1","unstructured":"Micro Labs Ltd. Phytoral ointment [Internet]. Available from: https:\/\/www.1mg.com\/drugs\/phytoral-ointment-329419"},{"key":"e_1_3_6_162_1","first-page":"1","volume-title":"Medical Product Alert N\u00b02\/2023: tetracycline hydrochloride ophthalmic ointment USP 1%.","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Medical Product Alert N\u00b02\/2023: tetracycline hydrochloride ophthalmic ointment USP 1%. World Heal. Organ; 2023. p. 1\u20134."},{"key":"e_1_3_6_163_1","first-page":"1612","article-title":"Safety and efficacy of a combination of chloramphenicol, polymyxin-b and dexamethasone in ocular infection with inflammation","volume":"03","author":"Kiran MD","year":"2018","unstructured":"Kiran MD, Sheikh SN, Pawaskar LJ. Safety and efficacy of a combination of chloramphenicol, polymyxin-b and dexamethasone in ocular infection with inflammation. Int J Innov Res Med Sci. 2018;03:1612\u20131617.","journal-title":"Int J Innov Res Med Sci."},{"key":"e_1_3_6_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(87)90103-2"},{"key":"e_1_3_6_165_1","doi-asserted-by":"publisher","DOI":"10.2174\/0115701808287654240126112003"}],"container-title":["Therapeutic Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20415990.2024.2346047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T21:49:30Z","timestamp":1727214570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/20415990.2024.2346047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,2]]},"references-count":163,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,2]]}},"alternative-id":["10.1080\/20415990.2024.2346047"],"URL":"https:\/\/doi.org\/10.1080\/20415990.2024.2346047","relation":{},"ISSN":["2041-5990","2041-6008"],"issn-type":[{"value":"2041-5990","type":"print"},{"value":"2041-6008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}